Autophagy inhibition of hsa-miR-19a-3p/19b-3p by targeting TGF-β R II during TGF-β1-induced fibrogenesis in human cardiac fibroblasts

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zou, Meijuan ^a   Wang, Fang ^a   Gao, Rui ^a   Wu, Jingjing ^a   Ou, Yingwei ^a   Chen, Xuguan ^a   Wang, Tongshan ^a   Zhou, Xin ^a   Zhu, Wei ^a   Li, Ping ^b   Qi, Lian Wen ^b   Jiang, Ting ^a   Wang, Weiwei ^a   Li, Chunyu ^a   Chen, Jun ^a   He, Qifang ^a   Chen, Yan ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3' UNTRANSLATED REGION; BIOLOGICAL MARKER; MICRORNA; MIRN19 MICRORNA, HUMAN; PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

3' UNTRANSLATED REGION; AUTOPHAGY; BINDING SITE; CARDIAC MUSCLE; CELL CULTURE; CELL LINE; CELL PROLIFERATION; DRUG EFFECTS; FIBROBLAST; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; HEART VALVE; HUMAN; METABOLISM; PATHOLOGY; RNA INTERFERENCE;

3' UNTRANSLATED REGIONS; AUTOPHAGY; BINDING SITES; BIOMARKERS; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; FIBROBLASTS; FIBROSIS; GENE EXPRESSION REGULATION; HEART VALVES; HUMANS; MICRORNAS; MYOCARDIUM; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA INTERFERENCE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84964842234     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep24747     Document Type: Article

References (68)

1. McKinsey, T. A. & Olson, E. N. Toward transcriptional therapies for the failing heart: chemical screens to modulate genes. J Clin Invest 115, 538-546, doi: 10.1172/JCI24144 (2005).
2. Zhou, J. et al. Engineering the heart: evaluation of conductive nanomaterials for improving implant integration and cardiac function. Sci Rep 4, 3733, doi: 10.1038/srep03733 (2014).
3. Yamada, T. et al. Relationship of myocardial fibrosis to left ventricular and mitochondrial function in nonischemic dilated cardiomyopathy-a comparison of focal and interstitial fibrosis. J Card Fail 19, 557-564, doi: 10.1016/j.cardfail.2013.05.018 (2013).
4. Dobaczewski, M., Chen, W. & Frangogiannis, N. G. Transforming growth factor (TGF)-beta signaling in cardiac remodeling. J Mol Cell Cardiol 51, 600-606, doi: 10.1016/j.yjmcc.2010.10.033 (2011).
5. Mascareno, E. et al. Cardiac lineage protein-1 (CLP-1) regulates cardiac remodeling via transcriptional modulation of diverse hypertrophic and fibrotic responses and angiotensin II-transforming growth factor beta (TGF-beta1) signaling axis. J Biol Chem 287, 13084-13093, doi: 10.1074/jbc.M111.288944 (2012).
6. Tarquini, R., Lazzeri, C., Pala, L., Rotella, C. M. & Gensini, G. F. The diabetic cardiomyopathy. Acta Diabetol 48, 173-181, doi: 10.1007/s00592-010-0180-x (2011).
7. Murarka, S. & Movahed, M. R. Diabetic cardiomyopathy. J Card Fail 16, 971-979, doi: 10.1016/j.cardfail.2010.07.249 (2010).
8. Gonzalez, A., Lopez, B., Querejeta, R. & Diez, J. Regulation of myocardial fibrillar collagen by angiotensin II. A role in hypertensive heart disease? J Mol Cell Cardiol 34, 1585-1593 (2002).
9. Puntmann, V. O. et al. Aortic stiffness and interstitial myocardial fibrosis by native T1 are independently associated with left ventricular remodeling in patients with dilated cardiomyopathy. Hypertension 64, 762-768, doi: 10.1161/ HYPERTENSIONAHA.114.03928 (2014).
10. Brooks, W. W. & Conrad, C. H. Myocardial fibrosis in transforming growth factor beta(1)heterozygous mice. J Mol Cell Cardiol 32, 187-195, doi: 10.1006/jmcc.1999.1065 (2000).
11. Burchfield, J. S., Xie, M. & Hill, J. A. Pathological ventricular remodeling: mechanisms: part 1 of 2. Circulation 128, 388-400, doi: 10.1161/CIRCULATIONAHA.113.001878 (2013).
12. Kingsley, D. M. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8, 133-146 (1994).
13. Brand, T. & Schneider, M. D. Transforming growth factor-beta signal transduction. Circ Res 78, 173-179 (1996).
14. del Pilar Alatorre-Carranza, M. et al. Liver fibrosis secondary to bile duct injury: correlation of Smad7 with TGF-beta and extracellular matrix proteins. BMC Gastroenterol 9, 81, doi: 10.1186/1471-230X-9-81 (2009).
15. Sui, X., Wei, H. & Wang, D. Novel mechanism of cardiac protection by valsartan: synergetic roles of TGF-beta1 and HIF-1alpha in Ang II-mediated fibrosis after myocardial infarction. J Cell Mol Med 19, 1773-1782, doi: 10.1111/jcmm.12551 (2015).
16. Montfort, I. & Perez-Tamayo, R. The distribution of collagenase in normal rat tissues. J Histochem Cytochem 23, 910-920 (1975).
17. Horn, M. A. et al. Age-related divergent remodeling of the cardiac extracellular matrix in heart failure: collagen accumulation in the young and loss in the aged. J Mol Cell Cardiol 53, 82-90, doi: 10.1016/j.yjmcc.2012.03.011 (2012).
18. Collier, P. et al. Getting to the heart of cardiac remodeling; how collagen subtypes may contribute to phenotype. J Mol Cell Cardiol 52, 148-153, doi: 10.1016/j.yjmcc.2011.10.002 (2012).
19. Levick, S. P. & Brower, G. L. Regulation of matrix metalloproteinases is at the heart of myocardial remodeling. Am J Physiol Heart Circ Physiol 295, H1375-1376, doi: 10.1152/ajpheart.907.2008 (2008).
20. Spinale, F. G. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 87, 1285-1342, doi: 10.1152/physrev.00012.2007 (2007).
21. Jugdutt, B. I. Matrix metalloproteinases as markers of adverse remodeling after myocardial infarction. J Card Fail 12, 73-76, doi: 10.1016/j.cardfail.2005.10.001 (2006).
22. Wieser, R., Wrana, J. L. & Massague, J. GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex. EMBO J 14, 2199-2208 (1995).
23. Lee, S. C., Kim, S. H., Koh, H. J. & Kwon, O. W. TGF-betas synthesized by RPE cells have autocrine activity on mesenchymal transformation and cell proliferation. Yonsei Med J 42, 271-277 (2001).
24. Liu, X. et al. Negative interplay of retinoic acid and TGF-beta signaling mediated by TG-interacting factor to modulate mouse embryonic palate mesenchymal-cell proliferation. Birth Defects Res B Dev Reprod Toxicol 101, 403-409, doi: 10.1002/bdrb.21130 (2014).
25. Hsu, Y. C., Chen, M. J., Yu, Y. M., Ko, S. Y. & Chang, C. C. Suppression of TGF-beta1/SMAD pathway and extracellular matrix production in primary keloid fibroblasts by curcuminoids: its potential therapeutic use in the chemoprevention of keloid. Arch Dermatol Res 302, 717-724, doi: 10.1007/s00403-010-1075-y (2010).
26. Tseng, Z. H. et al. Association of TGFBR2 polymorphism with risk of sudden cardiac arrest in patients with coronary artery disease. Heart Rhythm 6, 1745-1750, doi: 10.1016/j.hrthm.2009.08.031 (2009).
27. McKnight, A. J., Savage, D. A., Patterson, C. C., Sadlier, D. & Maxwell, A. P. Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy. BMC Med Genet 8, 5, doi: 10.1186/1471-2350-8-5 (2007).
28. Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8, 445-544 (2012).
29. Zou, M. et al. Beclin 1-mediated autophagy in hepatocellular carcinoma cells: implication in anticancer efficiency of oroxylin A via inhibition of mTOR signaling. Cell Signal 24, 1722-1732, doi: 10.1016/j.cellsig.2012.04.009 (2012).
30. Zou, M. et al. Oroxylin A induces autophagy in human malignant glioma cells via the mTOR-STAT3-Notch signaling pathway. Mol Carcinog 54, 1363-1375, doi: 10.1002/mc.22212 (2015).
31. Levine, B. & Klionsky, D. J. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 6, 463-477 (2004).
32. He, C. & Klionsky, D. J. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 43, 67-93, doi: 10.1146/ annurev-genet-102808-114910 (2009).
33. Berry, D. L. & Baehrecke, E. H. Autophagy functions in programmed cell death. Autophagy 4, 359-360 (2008).
34. Yeganeh, B. et al. Asthma and influenza virus infection:focusing on cell death and stress pathways in influenza virus replication. Iran J Allergy Asthma Immunol 12, 1-17, doi: 012.01/ijaai.117 (2013).
35. Ghavami, S. et al. Autophagy is a regulator of TGF-beta1-induced fibrogenesis in primary human atrial myofibroblasts. Cell Death Dis 6, e1696, doi: 10.1038/cddis.2015.36 (2015).
36. Nakai, A. et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med 13, 619-624, doi: 10.1038/nm1574 (2007).
37. Taneike, M. et al. Inhibition of autophagy in the heart induces age-related cardiomyopathy. Autophagy 6, 600-606, doi: 10.4161/ auto.6.5.11947 (2010).
38. Carthew, R. W. & Sontheimer, E. J. Origins and Mechanisms of miRNAs and siRNAs. Cell 136, 642-655, doi: 10.1016/j. cell.2009.01.035 (2009).
39. Ambros, V. The functions of animal microRNAs. Nature 431, 350-355, doi: 10.1038/nature02871 (2004).
40. Xu, J., Wang, Y., Tan, X. & Jing, H. MicroRNAs in autophagy and their emerging roles in crosstalk with apoptosis. Autophagy 8, 873-882, doi: 10.4161/auto.19629 (2012).
41. Vettori, S., Gay, S. & Distler, O. Role of MicroRNAs in Fibrosis. Open Rheumatol J 6, 130-139, doi: 10.2174/1874312901206010130 (2012).
42. Selcuklu, S. D. et al. MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells. J Biol Chem 287, 29516-29528, doi: 10.1074/jbc.M111.335943 (2012).
43. Su, Z., Yang, Z., Xu, Y., Chen, Y. & Yu, Q. MicroRNAs in apoptosis, autophagy and necroptosis. Oncotarget 6, 8474-8490, doi: 10.18632/oncotarget.3523 (2015).
44. Zhao, Y. et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129, 303-317, doi: 10.1016/j.cell.2007.03.030 (2007).
45. Wang, J. et al. MicroRNA-24 regulates cardiac fibrosis after myocardial infarction. J Cell Mol Med 16, 2150-2160, doi: 10.1111/j.1582-4934.2012.01523.x (2012).
46. Ge, Y. et al. MicroRNA-350 induces pathological heart hypertrophy by repressing both p38 and JNK pathways. Biochim Biophys Acta 1832, 1-10, doi: 10.1016/j.bbadis.2012.09.004 (2013).
47. Ucar, A. et al. The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat Commun 3, 1078, doi: 10.1038/ncomms2090 (2012).
48. Ikeda, S. et al. Altered microRNA expression in human heart disease. Physiol Genomics 31, 367-373, doi: 10.1152/ physiolgenomics.00144.2007 (2007).
49. Yang, H. et al. Wogonin induces cell cycle arrest and erythroid differentiation in imatinib-resistant K562 cells and primary CML cells. Oncotarget 5, 8188-8201, doi: 2340/oncotarget2340 (2014).
50. Zhang, J. et al. MicroRNA-638 inhibits cell proliferation, invasion and regulates cell cycle by targeting tetraspanin 1 in human colorectal carcinoma. Oncotarget 5, 12083-12096, doi: 10.18632/oncotarget.2499 (2014).
51. Khan, S. et al. MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer. Oncotarget 5, 7599-7609, doi: 10.18632/oncotarget.2281 (2014).
52. Konno, Y. et al. MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells. Oncotarget 5, 6049-6062, doi: 10.18632/oncotarget.2157 (2014).
53. Xu, X. M. et al. MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5. Cancer Lett 322, 148-158, doi: 10.1016/j.canlet.2012.02.038 (2012).
54. Zile, M. R. et al. Relationship between the temporal profile of plasma microRNA and left ventricular remodeling in patients after myocardial infarction. Circ Cardiovasc Genet 4, 614-619, doi: 10.1161/CIRCGENETICS.111.959841.
55. Zhao, D. S. et al. Serum miR-210 and miR-30a expressions tend to revert to fetal levels in Chinese adult patients with chronic heart failure. Cardiovasc Pathol 22, 444-450, doi: 10.1016/j.carpath.2013.04.001 (2013).
56. Sanbe, A. Dilated cardiomyopathy: a disease of the myocardium. Biol Pharm Bull 36, 18-22 (2013).
57. Vrtovec, B. et al. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up. Circ Res 112, 165-173, doi: 10.1161/CIRCRESAHA.112.276519 (2013).
58. Chun, J. L., OBrien, R., Song, M. H., Wondrasch, B. F. & Berry, S. E. Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn- /- but not aged mdx mouse models for duchenne muscular dystrophy. Stem Cells Transl Med 2, 68-80, doi: 10.5966/sctm.2012-0107 (2013).
59. Lelakowski, J. et al. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy. Kardiol Pol 70, 1264-1275 (2012).
60. Mozid, A. M., Arnous, S., Sammut, E. C. & Mathur, A. Stem cell therapy for heart diseases. Br Med Bull 98, 143-159, doi: 10.1093/ bmb/ldr014 (2011).
61. Brunner, S. et al. Left ventricular functional assessment in murine models of ischemic and dilated cardiomyopathy using [18 F] FDG-PET: comparison with cardiac MRI and monitoring erythropoietin therapy. EJNMMI Res 2, 43, doi: 10.1186/2191-219X-2-43 (2012).
62. Gosselin-Badaroudine, P. et al. A proton leak current through the cardiac sodium channel is linked to mixed arrhythmia and the dilated cardiomyopathy phenotype. PLoS One 7, e38331, doi: 10.1371/journal.pone.0038331 (2012).
63. Tachi, M. et al. Relationship of postcontrast myocardial T1 value and delayed enhancement to reduced cardiac function and serious arrhythmia in dilated cardiomyopathy with left ventricular ejection fraction less than 35. Acta Radiol, doi: 10.1177/0284185115580840 (2015).
64. Callis, T. E. et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest 119, 2772-2786, doi: 10.1172/JCI36154 (2009).
65. Mizushima, N., Levine, B., Cuervo, A. M. & Klionsky, D. J. Autophagy fights disease through cellular self-digestion. Nature 451, 1069-1075, doi: 10.1038/nature06639 (2008).
66. Mehrpour, M., Esclatine, A., Beau, I. & Codogno, P. Autophagy in health and disease. 1. Regulation and significance of autophagy: an overview. Am J Physiol Cell Physiol 298, C776-785, doi: 10.1152/ajpcell.00507.2009 (2010).
67. Mancias, J. D. & Kimmelman, A. C. Targeting autophagy addiction in cancer. Oncotarget 2, 1302-1306, doi: 10.18632/oncotarget.384 (2011).
68. Xu, Y. et al. Tgf-beta1 induces autophagy and promotes apoptosis in renal tubular epithelial cells. Int J Mol Med 29, 781-790, doi: 10.3892/ijmm.2012.911 (2012).